CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Bavarian Nordic AS - ADR Company Snapshot
Bavarian Nordic AS operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bavarian Nordic AS with three other companies in this sector in UNITED STATES : Precigen Inc (2019 sales of $90.72 million of which 100% was Synthetic Biology), Vericel Corp ($117.85 million of which 100% was Autologous Cell Products), and Sangamo Therapeutics Inc ($102.43 million of which 100% was Research & Colloboration).

Sales Analysis. Bavarian Nordic AS reported sales of $99.19 million for the year ending December of 2019. This represents an increase of 25.3% versus 2018, when the company's sales were $79.13 million. Despite this increase, sales are still well below the level achieved in 2017, when Bavarian Nordic AS reported sales of $209.82 million.
   
   
 
  Stock Performance Chart for Bavarian Nordic AS - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 9.61
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
 
Bavarian Nordic AS - ADR Key Data:
  Ticker: BVNRY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 99,187,703
(Year Ending Jan 2020).
Employees: 324
  Currency: U.S. Dollars Market Cap: 1,681,419,047
  Fiscal Yr Ends: December Shares Outstanding: 174,965,562
  Share Type: Common Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.